Abstract:Epidemiologic and clinical features of Kawasaki Disease (KD) strongly support an infectious etiology. KD is worldwide, most prominently in Japan, Korea, and Taiwan, reflecting increased genetic susceptibility among Asian populations. In Hawaii, KD rates are 20-fold higher in Japanese ethnics than in Caucasians, intermediate in other ethnicities. The age distribution of KD, highest in children < 2 yo, lower in those < 6 months, is compatible with infection by a ubiquitous agent resulting in increasing immunity with age and with transplacental immunity, as with some classic viruses. The primarily winter-spring KD seasonality and well-documented Japanese epidemics with wave-like spread also support an infectious trigger. We hypothesize KD pathogenesis involves an RNA virus that usually causes asymptomatic infection but KD in a subset of genetically predisposed children. CD8 T cells, oligoclonal IgA, and upregulation of cytotoxic T cell and interferon pathway genes in the coronaries in fatal KD also support a viral etiology. Cytoplasmic inclusion bodies in ciliated bronchial epithelium identified by monoclonal antibodies made from oligoclonal IgA heavy chains also supports a viral etiology. Recent availability of "second generation" antibodies from KD peripheral blood plasmablasts may identify a specific viral antigen. Thus, we propose an unidentified ("new") RNA virus infects bronchial epithelium usually causing asymptomatic infection but KD in a subset of genetically predisposed children. The agent persists in inclusion bodies, with intermittent respiratory shedding, entering the bloodstream via macrophages targeting coronaries. Antigen-specific IgA plasma cells and CD8 T cells respond but coronaries can be damaged. IVIG may include antibody against the agent. Post infection, 97-99% of KD patients are immune to the agent, protected against recurrence. The agent can spread either from those with asymptomatic primary infection in winter-spring or from a previously infected contact who intermittently sheds the agent.

A nomogram for predicting coronary artery lesions in patients with Kawasaki disease

Development of a nomogram prediction model for early identification of persistent coronary artery aneurysms in kawasaki disease

Development of a prediction model for progression of coronary artery lesions in Kawasaki disease

A nomogram prediction of coronary artery dilation in Kawasaki diseases based on mtDNA copy number

Preventing coronary artery lesions in Kawasaki disease

Identification of clinical risk factors for coronary artery lesions in children with Kawasaki disease: a retrospective cohort study

A new scoring system to predict Kawasaki disease with coronary artery lesions

Neutrophil-to-lymphocyte ratio and scoring system for predicting coronary artery lesions of Kawasaki disease

Study Progress of Coronary Artery Damage in Kawasaki Disease

A prediction model for coronary artery abnormalities in children with Kawasaki disease older than 5 years

Use of Harada Score in the Prediction of Coronary Arterial Lesions in Kawasaki Disease

Predictive Value of Red Blood Cell Distribution Width for Coronary Artery Lesions in Patients with Kawasaki Disease

Indicators of Oxidative Stress in the Prediction of Coronary Artery Lesions in Patients With Kawasaki Disease

A novel nomogram model for differentiating Kawasaki disease from sepsis

Kawasaki Disease and Coronary Artery Involvement: A Narrative Review

The Epidemiology and Pathogenesis of Kawasaki Disease

A new scoring system for coronary artery abnormalities in Kawasaki disease

Clinical analysis of 201 patients with Kawasaki disease:what are the high risk factors

547 cases of Kawasaki disease and related risk factors of coronary artery lesion

Single-Cell Transcriptome Reveals Potential Mechanisms for Coronary Artery Lesions in Kawasaki Disease

The Systemic Immune-Inflammation Index (SII) and coronary artery lesions in Kawasaki disease